A task force details its findings of the risks associated with using convalescent plasma using failure mode and effects analysis
Ravindra Khare
Advertisement
Ravindra Khare is CSO of SymphonyTech Biologics
Articles by Ravindra Khare
Advertisement
Latest Updated Articles
- A Systematic Evaluation of Risks and Mitigation Strategies for Convalescent Plasma Therapy for COVID-19
Published: February 3rd 2021 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Challenges, Innovations, and Future Outlook of Biologics Formulations
2
A-TEEM: A Novel, Powerful Tool for Evaluating and Monitoring Cell Culture Media
3
Global Study Confirms Survival Advantage of Mogamulizumab in Advanced Mycosis Fungoides and Sézary Syndrome
4
Behind the Headlines Episode 27: Unpacking Mega Deals and R&D Directions
5
